CDKN2A and esophageal squamous cell carcinoma: Recently, whole exome sequencing studies in ESCC have been reported, [24, 25] uncovering recurrent somatic mutations in TP53 (60-93%), CDKN2A (3-8%), RB1 (8-9%), PIK3CA (7-9%) and PTEN (5%).